MEPSGEN
Seoul, KR · 4 known investors
Find your way into MEPSGEN
Sign up to see every warm intro you have to MEPSGEN
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MEPSGEN team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MEPSGEN develops microphysiological systems (MPS) and organ-on-chip technologies for drug development and testing, serving pharmaceutical companies and contract research organizations. The company manufactures nanoparticles and microspheres, produces automated robotic systems for MPS modeling, and develops nanomedicines for diseases including glioblastoma and Alzheimer's disease.
Investors · 4
Kolon Investment, Inc.✓ confirmed by MEPSGENSeoul
How we know: the company's own site · Not right? Tell us
Korea Investment Partners✓ confirmed by MEPSGENSeoul · $3M – $10M
How we know: the company's own site · Not right? Tell us
Frequently asked questions
- What does MEPSGEN do?
- MEPSGEN develops microphysiological systems (MPS) and organ-on-chip technologies for drug development and testing, serving pharmaceutical companies and contract research organizations. The company manufactures nanoparticles and microspheres, produces automated robotic systems for MPS modeling, and develops nanomedicines for diseases including glioblastoma and Alzheimer's disease.
- Who are MEPSGEN's investors?
- MEPSGEN's investors include Kolon Investment, Inc., Korea Investment Partners, SBI Investment Korea Co. Ltd., Solidus Investment.
- Where is MEPSGEN headquartered?
- MEPSGEN is headquartered in Seoul, KR.